Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

ESO Announces Peer-Reviewed Research Describing Characteristics of COVID-19 EMS Encounters with Linked Hospital Diagnoses


The robust dataset provides key insights in regard to EMS impressions, hospital diagnoses and the use of PPE.

ESO, the leading data and software company serving emergency medical services (EMS), fire departments, hospitals, and state EMS/Trauma offices, today announced publication of research in Prehospital Emergency Care (PEC) related to COVID-19 in the prehospital and hospital setting entitled: COVID-19 Preliminary Case Series: Characteristics of EMS Encounters with Linked Hospital Diagnoses. The report looks at more than 84,500 records for patients transported between March 1 and April 19, 2020 with linked hospital ICD-10 codes included. The objective of the report is to describe prehospital encounters for patients with a COVID-19 hospital diagnosis and/or COVID-19 EMS suspicion versus those with neither a hospital diagnosis nor EMS suspicion to inform Personal Protective Equipment (PPE) usage by EMS providers.

“We’ve worked closely with our customers to capture and analyze data related to COVID-19 in an effort to help first responders and hospitals best serve their communities in light of this pandemic,” said Dr. Brent Myers, Chief Medical Officer for ESO. “The robust dataset provides key insights in regard to EMS impressions, hospital diagnoses and the use of PPE. While Fire and EMS professionals were able to correctly identify nearly 80 percent of patients who were ultimately diagnosed with COVID-19 disease in the hospital, there remained 20 percent of patients whose disease was undetected in the prehospital environment. Providers should consider broad utilization of PPE in order to protect themselves.”

Key Findings from the Report Include:

  • COVID-19 Diagnoses and Ailments: Those with COVID-19 hospital diagnoses were more likely to present with elevated heart and respiratory rate, hypoxia and fever during the EMS encounter.
  • COVID-19 Suspicion: A COVID-19 EMS suspicion was documented for 78 percent of hospital-diagnosed COVID-19 patients.
  • Patient Origin: EMS responses for patients with COVID-19 were more likely to originate from a skilled nursing or assisted living facility.
  • PPE Usage: PPE usage by EMS was more frequently documented on records of patients who had hospital diagnosed COVID-19.
  • Dispatch Complaints: While dispatch complaints for hospital-confirmed COVID-19 patients most commonly included general illness and breathing difficulties, there were also cases dispatched as falls, chest pain, and strokes.
  • Demographic Insights: Consistent with reported in-hospital findings, African American and Hispanic patients made up a disproportionately larger number of COVID-19 diagnoses.


“We are committed to improving the health and safety of communities through the power of data,” added Dr. Myers. “We join the nation in gratitude for all of the first responders who care for us in these truly difficult times. We also want to thank all of the agencies who voluntarily participate in the ESO Data Collaborative, allowing us to utilize de-identified data to evaluate EMS care from 9-1-1 call to hospital discharge for a wide range of conditions, and now particularly with COVID-19. We are continually evaluating these data and plan to provide updates to further assist EMS agencies and hospitals in our response to this pandemic.”

About the COVID-19 Study

This case series evaluated electronic patient care records from EMS agencies participating in the ESO Data Collaborative, a large national, bidirectional data exchange. Click here to view the report.

About ESO

ESO is dedicated to improving community health and safety through the power of data. Since its founding in 2004, the company continues to pioneer innovative, user-friendly software to meet the changing needs of today’s EMS agencies, fire departments, hospitals and state EMS offices. ESO currently serves thousands of customers throughout North America with a broad software portfolio, including the industry-leading ESO Electronic Health Record (EHR), the next generation ePCR; ESO Health Data Exchange (HDE), the first-of-its-kind healthcare interoperability platform; ESO Fire RMS, the industry standard for fire Record Management Systems; trauma, burn and stroke registry software; and ESO State Repository. ESO is headquartered in  Austin,  Texas. For more information, visit http://www.eso.com.

Share article on social media or email:

Lawsuit Alleges Producer of Exosomes and Amniotic Fluid is Violating Multiple Federal Drug Administration Guidelines Including Intentionally Shipping Out Expired Products


The allegation is made that Kimera Labs intentionally shipped out expired products and then orchestrated a process to relabel the expired products and extend the product expiration date.

A lawsuit (Case# CACE-20-000455) been filed by Nevada-based Age Bio Marq Lab, LLC (ABM) against Kimera Labs, a manufacturer of stem cell derived exosomes and amniotic fluid. The lawsuit alleges that Kimera Labs has engaged in several illegal practices including: theft of trade secrets, internal mislabeling of the expiration date of biologic products, circumventing distributors by creating direct relationships with distributor’s clients at significantly better pricing, intentionally manipulating accounting figures, promotion of questionable manufacturer product opinions that are not in compliance with the Federal Drug Administration’s (FDA) guidance, and attempting to collect revenues already paid.

According to the complaint filed in the Circuit Court of the 17th Judicial Circuit in and for Broward County, Florida, Age Bio Marq Lab, which operates its distribution business as Stem Excell, executed a distribution agreement with Kimera Labs, the manufacturer of the FDA-regulated biologic product commonly known as exosomes. Exosomes are derived from stem cells growing in Kimera Labs’ facilities in Miramar, FL.

ABM alleges that many of the provisions of the distribution agreement have been violated by Kimera Labs and its employee and officer Adam Koster. Per the agreement, Kimera Labs agreed to protect the Age Bio Marq Lab’s relationships that it utilizes when selling its products. The agreement further assured that products manufactured by Kimera Labs are legal and compliant with Federal Laws and all relevant statutes. ABM alleges the products sold by Kimera Labs are not in compliance. The lawsuit includes recent letters and actions by the FDA supporting that allegation.

In February 2019, ABM began sending correspondence to Kimera Labs to inform them of the problems Koster was causing, including a cease and desist letter sent in September 2019. The lawsuit alleges the manufacturer disregarded all correspondence and refused to prevent Koster from continuing to cause damages to ABM’s operation. As described in the lawsuit, that damage includes Kimera Labs hiring of Koster to target clients of their distributors to increase its profit margin by not paying the distributors for distribution of the manufactured product.

ABM also alleges that Kimera Labs intended to violate the trade secrets and other provisions of its contract with ABM and also intentionally shipped out expired products. The lawsuit details a process orchestrated by the defendent to relabel expired products and extend the product expiration date.

Click here to read the entire lawsuit: https://www.ki-law.com/lawsuit-alleges-producer-of-exosomes-and-amniotic-fluid-is-violating-multiple-federal-drug-administration-guidelines-including-intentionally-shipping-out-expired-products/

Kenner + Imparato, PLLC is a general practice law firm servicing clients nationwide. We handle a variety of legal matters for individual and corporate clients. Kenner + Imparato, PLLC represent Age Bio Marq Lab, LLC in this case.

Share article on social media or email:

NEORIS Releases Next Generation HealthCheck Platform to Help Companies Plan a Safe Return to the Workplace


Our clients are focused on ensuring the wellbeing and safety of their employees while defining a new normal.

The recent resurgence of the COVID-19 pandemic is challenging public and private institutions to balance long-term business survival and continuity with protecting the wellbeing of the organization. A new normal means enabling employees to work remotely whilst providing a path to safely return to the workplace. This entails the ongoing monitoring and management of contagion risks that impact workplace viability in ways never before envisioned.

In response, the new release of the NEORIS HealthCheck platform enables employees and organizations to not only assess employee wellbeing based on CDC guidelines, but also incorporates comprehensive contact tracing; shift management to administer building occupancy based on social distancing guidelines; an advanced microblogging feature that allows employees to share vital information; and a comprehensive facility assessment module that is fully configurable to manage worksite viability. NEORIS has also significantly enhanced its KnowledgeTabs reporting platform that now provides dynamic analytics about people, facilities, relationships, contagion levels by country, state and city as well as powerful employee 360 and facility 360 views.

“Our clients are focused on ensuring the wellbeing and safety of their employees while defining a new normal that minimizes contagion risks and ensures long-term business sustainability. Assuring that employees and work teams can safely return to the workplace to foster ongoing collaboration and productivity is paramount,” said Anthony DeLima, NEORIS USA Country Manager. “Companies recognize that returning to the workplace is a shared responsibility that requires the close collaboration and commitment between employees, their managers, human resources and health and safety stakeholders. With the new release of the NEORIS HealthCheck platform we are leveraging state of the art technology to deliver extensive visibility on risks while predicting required actions to protect the organization.”

To support the initial response to COVID-19, NEORIS launched in March an advanced digital platform that consists of a mobile APP that enables employees to self-assess their wellbeing in accordance with CDC guidelines for infection symptoms together with a powerful reporting backend. As COVID-19 continues to spread and shows resurgence across the world, more advanced planning and support tools are required to allow employees to safely return to the workplace. The new release of NEORIS’ Healthcheck platform includes several powerful features:


  • Advanced KnowledgeTabs provides a single data hub to enable the organization to obtain a 360-degree view of the wellbeing of their employees and geolocation data to assess the impact of COVID-19 on business and workplace readiness. The platform allows public and private sector clients to have a comprehensive, real-time view of the impact of the pandemic on their operations in order to quickly respond.
  • Facility Assessment and Reporting allows companies to assess the viability of their facilities by allowing supervisors and health and safety professionals to ensure that facilities meet and exceed safety standards to minimize contagion using complex scoring algorithms to determine if a facility can be occupied. The platform provides a 360-degree view of all facilities in real-time. A shift management feature enables employees to schedule visits to the workplace taking into account capacity limitations based on social distancing guidelines.
  • Contact Tracing leverages state-of-the-art, anonymous contact tracing algorithms that use Bluetooth, Beacons, Fobs and/or QR Codes to manage potential contamination risks and rapidly respond to a resurgence within the workplace. In contrast to publicly available contact tracing technologies, NEORIS’ solution enables companies and employees to anonymously understand and dynamically track possible resurgence.
  • Powerful microblogging enables employees, human resource leaders and other stakeholders to remain in constant contact by sharing critical information and insights that can help reduce risks.

Restarting the US economy has proven to be a significant challenge driven by unforeseen risks. The new NEORIS HealthCheck platform is helping businesses to minimize risks by using advanced innovation to gather, analyze and interpret data in real-time to make better, more informed decisions about reopening. Planning a safe return to the workplace will continue to be challenging. NEORIS is committed to playing its part in helping public and private sector organizations to navigate a safe return to the workplace. Visit our site neoris.com/healthcheck for more information.

About NEORIS

NEORIS is a leading global digital accelerator that co-creates disruptive solutions for digitally aspirational companies to boost their connections with customers, employees and stakeholders; ignited by creative teams with deep industry knowledge and technical expertise. Headquartered in Miami, FL., NEORIS has a network of global delivery centers, design studios and operations in the U.S., Europe, Latin America, and India. More information is available at http://www.neoris.com, LinkedIn, Facebook, or Twitter.

CONTACT

Maria Moore

Client Relations at NEORIS

Maria.moore@neoris.com

Share article on social media or email:

Nutrition App, Lifesum, Develops Lifesum Games, Challenging Consumers to Develop a New Healthy Habit Every Week


The nutrition app, Lifesum, has announced they are kicking off the Lifesum Games, a set of nutrition-focused challenges for consumers to participate in from July 20th to August 9th. The Lifesum Games are designed to motivate participants to develop healthy habits.

The Lifesum Games include three major challenges: “Hydrate-a-thon,” “Track-ing and Field” and “Go for the Green to Get the Gold.” Each of these challenges motivates consumers to develop a new healthy habit to improve their overall health over the long term. Participants will win a gold, silver or bronze classification based on how well they performed throughout the Lifesum Games.

The CEO of Lifesum, Henrik Torstensson, says the Lifesum Games will help users unleash the motivation they need to stick with their health and fitness plans while stuck in quarantine.

“We put a lot of thought and research into the Lifesum Games, trying to develop challenges that will continue long past the end of the competition,” said Torstensson. “And research shows us if you can continue this habit for longer than three weeks, it will be easier to continue with this healthy habit months and years down the road.”

Hydrate-a-thon – Challenges Users to Drink More Water

The “Hydrate-a-thon” challenge requires participants to drink 8 glasses of water every day for the first week and track it in the app.

It can be hard to remember to drink enough water throughout the day, but, according to registered dietitians with Lifesum, staying hydrated makes weight loss easier, improves blood circulation, helps with the regulation of body temperature and aids in digestion. Even slight dehydration can negatively affect a consumer’s health.

Track-ing and Field – Challenges Users to Track Their Meals

The “Track-ing and Field” challenge asks participants to eat and track at least three meals each day for the second week.

According to Lifesum nutritionists, everyone needs a variety of energy sources and macronutrients, such as carbs, protein and fats – regardless of whether their goals are to lose, gain or maintain their body weight. Nutritionists say tracking all meals throughout the day will increase their chances of reaching their goals.

Go for the Green to Get the Gold – Challenges Users to Eat More Vegetables

The “Go for the Green to Get the Gold” challenge has participants eat and track three vegetables per day in the final week. Lifesum nutritionists say vegetables are an essential part of any diet since they provide dietary fiber, vitamins & minerals such as vitamin C and potassium. Fiber also lowers the risk of high cholesterol, cardiovascular disease, and obesity, while vitamin C is important for the connective tissue, skin, tissue and aids in the absorption of iron. Potassium maintains blood pressure, regulates fluid balance, and controls nerve signals.

Participate in Lifesum Games

The Lifesum Games will last three weeks with a new challenge beginning each Monday. When users open the app each Monday, a pop-up will ask users whether they want to participate.

With helpful notification reminders, users will be encouraged to stay on track and input their daily progress. Participants will find out on Sunday how they performed for the week and whether they won a gold, silver or bronze.

About Lifesum

Lifesum helps its 45 million users log what they eat and drink, when they exercise, their weight, and other lifestyle habits on the app. The app uses technology and psychology to create personalized plans for each user to help them achieve their goals, whether that be to get more fit, lose weight, or to lead a healthier lifestyle. Lifesum shows its users how implementing small habits each day can improve their overall health. Lifesum ranks in the Top 10 in the Health & Fitness section in the App Store and is the Editors’ Choice on Google Play. Consumers can download Lifesum for free on iOS or Android.

Media Contact

Mark Macias

mmm@maciaspr.com

646-770-0541

Share article on social media or email:

Meridian Clinical Research Opens Sites in Grand Island and Hastings, NE, Now Enrolling for COVID-19 Vaccine Studies


Meridian opens new research sites in Grand Island and Hastings, NE

Meridian opens new research sites in Grand Island and Hastings, NE

“Whether it’s someone seeking a new treatment option for a condition they’re fighting, or a healthy volunteer wanting to help advance medicine, Nebraskans can drive the development of next-generation therapies through clinical trials.” Nicole Osborn, CEO of Meridian

Meridian Clinical Research, a leading multi-specialty investigative research network, has opened new sites in Grand Island, NE, and Hastings, NE.

Meridian is partnering with Adam Brosz, MD, Erica Haake, MD, and Timothy Gardner, MD, in Grand Island. The physicians will serve as principal investigators to conduct clinical trials related to general medicine, women’s health, pediatrics, and infectious diseases. The site will operate within the Grand Island Clinic at 2444 West Faidley Avenue, Grand Island, Nebraska 68803.

In Hastings, Meridian is partnering with Tyler Adam, MD, and Daniel Leonard, DO, to oversee women’s health, pediatrics, and infectious disease clinical trials. The site will operate at 2115 N. Kansas Ave., Suite 102, Hastings, NE 68901, near the Obstetricians & Gynecologists, PC., and Children & Adolescent Clinic offices.

Meridian is currently enrolling participants for numerous COVID-19 vaccine trials at sites across the nation, including its location in Grand Island. Participants will receive study-related exams, and an investigational COVID-19 vaccine or placebo at no cost. Eligible participants will also receive compensation for study-related time and travel.

When COVID-19, Ebola, and the Zika virus outbreaks began in recent years, several Meridian sites in Nebraska were among the world’s first to enroll patients in vaccine studies.

Meridian’s Grand Island and Hastings sites will also begin conducting a study to determine if an investigational vaccine for mothers can prevent respiratory syncytial virus (RSV) illnesses in infants after they’re born.

“We’re excited to expand our reach in Nebraska with region-leading physicians,” said Nicole Osborn, Founder and CEO of Meridian. “Whether it’s someone seeking a new treatment option for a condition they’re fighting, or a healthy volunteer wanting to help advance medicine, Nebraskans can drive the development of next-generation therapies through clinical trials.”

Meridian was founded in Omaha in 1999, and has enrolled more than 42,000 participants into clinical trials. The company’s Grand Island and Hastings sites are now enrolling participants for clinical trials.

If you’re interested in joining a clinical trial at Meridian, visit mcrmed.com/find-study. For more information about careers at Meridian, visit mcrmed.com/careers.

—

ABOUT MERIDIAN CLINICAL RESEARCH

Meridian Clinical Research Meridian partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is a multi-specialty site network headquartered at its dedicated research center in Omaha, NE, and conducts Phase I-IV studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and excels in high-volume vaccine trials. For more information, visit mcrmed.com.

Share article on social media or email:

Commonwealth Primary Care ACO Marks the Launch of HGE Health’s COPD Digital Platform in Arizona


HGE Health

“Providers who adopt the HGE Care™ platform have realized significant reductions in the time patients have to wait to receive medical care for their COPD. We help offload most of the burden associated with providing immediate medical care from those providers,” Michael J Markus, CEO, HGE Health

Commonwealth Primary Care ACO, LLC (“Commonwealth”) has contracted with HGE Health to deploy the first large-scale remote symptom monitoring platform for respiratory patients in Arizona. The HGE Care™ clinically-validated platform offers enrolled patients a mobile application that they use to submit daily symptom reports to their healthcare provider. Symptom reports that suggest the onset of worsening symptoms are flagged by the HGE Care™, allowing nurses and health coaches staffing HGE Health’s call center to proactively coordinate medical intervention to those patients in need of care. Medical care is typically rendered to COPD patients the same day worsening symptoms are reported, often via telemedicine services that do not require affected patients to leave their homes to protect those most at risk from COVID-19, the spread of which continues to accelerate.

The HGE Care™ platform will be deployed on behalf of Commonwealth as a turnkey solution, eliminating the need for Commonwealth to build the vast infrastructure and hire the personnel required to offer remote symptom monitoring to patients. Clinically-validated algorithms of the HGE Care™ platform identify patients reporting changes in symptoms that may warrant provider review and intervention, and HGE Health’s clinical personnel provide patient triage and make treatment recommendations based on best in class clinical protocols. Commonwealth’s medical personnel, who will ultimately decide how to treat the patients, easily review the symptoms and triage notes, and sign off on any changes to the care plan of action within their existing digital care coordination platform. HGE’s contact center staff are available to patients twelve hours a day, three-hundred-seventy-five days a year, including weekends, after-hours, and holidays, providing broad access to clinical support without a corresponding burden to Commonwealth’s providers, nurses, and office staff.

Medical treatment approved by Commonwealth will be conveyed to the patients through the HGE Care™ mobile application, or via email or telephone call. Telemedicine interventions offer an added layer of protection to patients suffering from COPD, a significant underlying risk factor that makes them particularly susceptible to severe COVID-19 outcomes. Patients requiring urgent care can be instructed to seek in-person treatment by their primary care physician, or at an urgent or emergency care facility, as appropriate. HGE Care and the HGE staff provide clinical and billing documentation in the customer’s systems, allowing Commonwealth to seamlessly submit claims to payors according to its standard billing procedures.

“While considering the adoption of the HGE Care™ platform for our COPD patients we weighed the benefits of improving healthcare services against very few, if any obstacles that stood in our way,” explained Lance Donkerbrook, Commonwealth CEO. “The HGE Care™ platform is readily compatible with our EMR system, providing transparency into the daily conditions of our COPD patients, and documenting all information required for us to continue submitting claims according to our standard procedure. Aside from the added support from HGE Health’s clinical personnel staffing their call center, we can now offer improved patient care without experiencing any additional burdens or disruptions to our workflow. In the end, the decision to subscribe to HGE Care™ made sense.”

Michael J. Markus, CEO of HGE Health, also views HGE Health’s role as a “plug-and-play” service that complements existing healthcare services offered by its customers. “Healthcare providers who adopt the HGE Care™ platform have realized significant reductions in the time patients have to wait to receive medical care for their COPD, and we are able to offload most of the burden associated with providing immediate medical care from those providers,” Markus explained. “Respiratory patients previously had to wait several days or even weeks to get an appointment to see their primary care physician to treat flareups that occur without warning, understandably leading many patients to seek immediate emergency care to obtain relief. Detailed emergency treatment information may not make it back to the patient’s EMR maintained by their primary care physician, resulting in a lack of clarity into the daily progression of the patient’s COPD. Instead, we aim to allow primary care physicians to timely treat the occasional worsening of symptoms that COPD patients experience, and do so without drastic changes to the workflow of those physicians.”

The implementation of HGE Care™ in Arizona continues HGE Health’s westward expansion of respiratory services across the United States from its original deployment in Philadelphia. Other markets with a growing presence of HGE Care™ include Pennsylvania, Oklahoma, Texas, Michigan, New Jersey, and Florida.

About HGE Health

Headquartered in Fort Washington, PA, HGE Health harnesses its deep experience in chronic disease management and digital health in pulmonary disease, telemedicine, and mobile health to develop a clinical services platform that delivers better care faster at a much lower cost for patients, physicians, and payors. Built on clinical protocols developed and supported by 16 years of research, the company’s technology has compiled the longest-running and world’s largest longitudinal data set of COPD symptoms, interventions, and clinical management to help physicians provide care for a geographically and socio-economically diverse COPD and pulmonary patient population.

About Commonwealth Primary Care ACO, LLC

Commonwealth is a federally-chartered accountable care organization that operates in the greater Phoenix metropolitan area, Flagstaff and throughout AZ as a participant in the Medicare Shared Savings Program. Commonwealth is primary care based, owned, operated, and governed to provide innovation in care practices for the benefit of the members it serves.

Share article on social media or email:

NeoTract Designates Dr. Philip Weintraub as UroLift® Center of Excellence


News Image

“We are pleased to recognize Dr. Philip Weintraub as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Philip Weintraub, M.D., Urology Associates Medical Group in Burbank, CA, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Weintraub has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are pleased to recognize Dr. Philip Weintraub as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “This achievement has helped many patients experience durable, long- term relief from the burdensome symptoms of BPH while preserving sexual function*1,2.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Laitek Inc. Earns ISO Quality Management System Approval


Laitek Inc., innovators in rapid medical data migration and storage, is pleased to announce it has earned approval from the International Organization for Standardization (ISO) for its Quality Management System. The news comes following a remote audit conducted by SGS in May. A Quality Management System is a set of policies, processes, and procedures used to optimize Laitek’s core business. The objective of the two-day audit was to examine the management system, standard operating procedures, and business practices currently in place at Laitek. The purpose of implementing a Quality Management System is to control, measure, and improve business performance throughout the organization.

“Achieving the ISO certification represents our commitment to discipline as we continue to grow to meet the higher demands of the marketplace,” said Cameron Brackett, EVP and GM. “The commitment of our team to comply with ISO principals is essential for exceptional customer performance and continual improvement.”

Laitek is pleased to announce there were no non-conformities in the audit and the lead auditor noted the commitment of Laitek’s management team in the audit report, its focus on well implemented and analyzed training needs and commended Laitek’s operational strengths.

“This is an important milestone for our organization,” said Fred Behlen, Laitek President reflecting on the results of the audit. “It is a demonstration of the way we work, and our focus to improve our products and services for our customers. I’m really proud of what we’ve done and what we’ll do going forward. This commitment to excellence drives our customers toward success and really sets us apart from our competition.”

The International Organization for Standardization (ISO) is the world’s largest developer of voluntary International Standards focused on process improvement, safety, and quality. This independent, non-governmental international organization that has published more than 23,283 standards and has members in 163 countries, and 788 technical bodies for standard development.

About Laitek Inc.

Laitek delivers fast, accurate solutions in clinical data storage, sharing, migration, interoperability, and workflow, for PACS vendors and healthcare facilities. As experts in the healthcare data management industry, hospital IT management and of DICOM & HL7 standards development, Laitek offers decades of frontline experience serving healthcare providers to ensure they can secure, control, and efficiently manage their clinical data. For more information visit the company’s Web site at http://www.laitek.com.

Share article on social media or email:

Tech-enabled mask from Lumen Couture offers new forms of self-expression


Masks have become ubiquitous as a wardrobe staple, and are now becoming a fashion statement and a form of self-expression.

The Lumen Couture LED Display mask utilizes new paper-thin LED matrix screens to allow custom text, drawings, and voice inputs, all controlled through an app.

The mask has breathable sections above and below the tech, and the technology is fully removable for washing. When the tech component is removed, the fabric mask can be worn as a regular mask.

Text Display When Your Mouth is Hidden

The mask’s companion app offers microphone input that responds with equalizer functions. Some wearers of the mask have been using it to display text and sentences that would otherwise be difficult to see or hear when the mouth is covered. Many wearers use the “stand back” message to encourage others to stay away.

Political Statements and the Anti-Mask Movement

The mask has recently been used frequently in protests and political activism, particular within the BLM movement as many protestors have been wearing the masks with messaging and support for the cause.

The mask has also received criticism from the “anti-mask” movement, with accusations of normalizing government oppression of requiring people to wear masks, and, as one commenter described, “oppressive dystopian fashion for end times.”

Creation of the Mask

Lumen Couture’s founder Chelsea Klukas has been creating fashion that incorporates tech for over 8 years. Her regular line includes tech-enabled dresses, hoodies, and costumes with customizable features.

The mask was invented when the pandemic was starting to take hold. Regular sales were slowing and events were cancelled, and Klukas was feeling somewhat demotivated due to the slowdown of the business. Klukas had planned to create some regular fabric masks using extra materials to distribute to friends, when she had the idea to combine some of the existing tech components to create the mask. The mask was originally posted it as a DIY project with instructions, but due to the massive interest it was quickly pivoted to production as part of my ready-to-wear line. Since launch, the mask has been in high demand and on backorder as Lumen Couture scaled up production to match the unexpected demand, but is now scaled up and available for immediate fulfillment. As a way to give back, Lumen Couture donated proceeds from sales from launch until June to The WHO COVID-19 relief and raised nearly $5K USD.

The mask can be purchased at http://www.lumencouture.com/buy-led-light-up-dresses/shop-tech-warning-face-mask/

Share article on social media or email:

Drinking Fountain Lockout Device offers simple, safe solution for schools


Emedco, a national safety company headquartered in Buffalo, has developed an innovative solution to restrict drinking fountain use in schools as a measure to prevent the spread of COVID-19.

The onset of summer and the eventual next school year presents a challenge to education administrators to take drastic measures to prevent the spread of coronavirus, especially in high traffic areas in schools. This new device provides an easy-to-install bright red physical barrier made of tamper-resistant polypropylene that will completely cover the fountain spout and lock in place.

“This is a simple, clean solution for preventing the spread of COVID-19 in schools through stopping the use of water fountains,” said Paul Schneeberger, the product manager behind the device. “Whether preschool or high school students, this will help keep people safe.”

While the device will prevent water fountain usage, it won’t prevent water flow to a bottle-filling station that might also be connected to the water fountain so staff and students can remain hydrated.

As an added bonus, the device can then be used to lock out standard plug valves within the stem diameter range when the pandemic is over.

Product Specifications:


  • Constructed of highly-visible, tamper-resistant polypropylene
  • Withstands service temperatures from -25°F to 200°F.
  • Compliant with OSHA requirement 1910.147
  • Maximum Stem Diameter: 2.125 in
  • Stem Diameter Range: 1.75 in to 2.125 in


About Emedco:

For over 70 years Emedco has been the leading manufacturer and distributor of signs and identification products for the workplace. Our line of custom products are designed to provide safe and secure solutions for businesses.

Emedco is owned by Brady Corporation. More information is available at http://www.bradycorp.com.

Share article on social media or email: